Article metrics

  • citations in SCindeks: 0
  • citations in CrossRef:[1]
  • citations in Google Scholar:[=>]
  • visits in previous 30 days:9
  • full-text downloads in 30 days:5
article: 10 from 12  
Back back to result list
Medicinski časopis
2016, vol. 50, iss. 3, pp. 107-109
article language: Serbian
document type: Case Report
published on: 31/03/2017
doi: 10.5937/mckg50-13006
Toxic megacolon associated with Clostridium difficile infection: A case study
aUniversity of Kragujevac, Faculty of Medicine + Clinical Centre Kragujevac, Clinic for Infectious Diseases
bUniversity of Kragujevac, Faculty of Medicine, Department of Pharmacology and Toxicology
cUniversity of Kragujevac, Faculty of Medicine
dVisoka medicinska škola strukovnih studija Ćuprija, Ćuprija

e-mail: rakovic.ivana.kg@gmail.com

Abstract

Hyper virulent bacterial strain and irrational antibiotics use are among main causes of incidence increase in Clostridium difficile infection. The most difficult complication of clostridia infection is toxic megacolon with the incidence of 0.4 - 3 % of cases. The study shows a female 56-year-old patient hospitalized at Infectious Disease Clinic in Kragujevac, on the fourth day of the disease, with stomach ache, nausea, vomiting and diarrhea. The patient was previously hospitalized at Pulmonary Clinic for twenty-two days where she had been treated for pneumonia with combined antibiotic therapy. Laboratory analyses showed increased levels of leucocytes (WBC 50.4h109A), nitrates (urea: 15.4 mmol/l, creatinine: 328 mmol/L) and C-reactive proteins (CRP: 221.2 mg/L), while albumin levels were decreased (16 g/L). Stool was positive on Clostridium difficile. Computerized tomography (CT) was used to visualize diffuse thickening of colon s wall, especially ascendant, with peritoneum density increase and the presence of free liquid. Despite eradication antibiotic (amp. Vankomycin 125mg/6h per os, amp. Orvagyl 500mg/8h iv), substitution and symptomatic therapy, as well as multidisciplinary approach, the patient passed away on the third day of hospitalization. Recognizing risk factors for clostridia infection onset, monitoring clinical course of the disease, adequate medicament therapy, and early surgical intervention due to complications can lead to lower morbidity and mortality infection rates.

Keywords

References

Berman, L., Carling, T., Fitzgerald, T.N., Bell, R.L., Duffy, A.J., Longo, W.E., Roberts, K.E. (2008) Defining Surgical Therapy for Pseudomembranous Colitis With Toxic Megacolon. Journal of Clinical Gastroenterology, 42(5): 476-480
Carchman, E.H., Peitzman, A.B., Simmons, R.L., Zuckerbraun, B.S. (2012) The role of acute care surgery in the treatment of severe, complicated Clostridium difficile–associated disease. Journal of Trauma and Acute Care Surgery, 73(4): 789-800
Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, C.L., Pepin, J., Wilcox, M.H. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection control and hospital epidemiology, 31(5): 431-55
Earhart, M.M. (2008) The Identification and Treatment of Toxic Megacolon Secondary to Pseudomembranous Colitis. Dimensions of Critical Care Nursing, 27(6): 249-254
Hensgens, M.P.M., Goorhuis, A., Dekkers, O.M., Kuijper, E.J. (2011) Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. Journal of Antimicrobial Chemotherapy, 67(3): 742-748
Hookman, P., Barkin, J.S. (2009) Clostridium difficile associated infection, diarrhea and colitis. World journal of gastroenterology, 15(13): 1554-80
Kazanowski, M., Smolarek, S., Kinnarney, F., Grzebieniak, Z. (2013) Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities—a systematic review. Techniques in Coloproctology, 18(3): 223-232
Khanna, S., Pardi, D.S., Aronson, S.L., Kammer, P.P., Orenstein, R., St, S.J.L., Harmsen, W., Zinsmeister, A.R. (2012) The epidemiology of community-acquired Clostridium difficile infection: a population-based study. American journal of gastroenterology / Am. J. Gastroenterol., 107(1): 89-95
Lamontagne, F., Labbé, A., Haeck, O., Lesur, O., Lalancette, M., Patino, C., Leblanc, M., Laverdière, M., Pépin, J. (2007) Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Annals of surgery, 245(2): 267-72
Leifeld, L., Kruis, W. (2012) Management des toxischen Megakolons. Zeitschrift für Gastroenterologie, 50(03): 316-322
Markelov, A., Livert, D., Kohli, H. (2011) Predictors of fatal outcome after colectomy for fulminant Clostridium difficile Colitis: a 10-year experience. Am Surg, 77: 977-80
Sailhamer, E.A. (2009) Fulminant Clostridium difficile Colitis. Archives of Surgery, 144(5): 433
Sayedy, L. (2010) Toxic megacolon associatedClostridium difficilecolitis. World Journal of Gastrointestinal Endoscopy, 2(8): 293
Surawicz, C.M., Brandt, L.J., Binion, D.G., Ananthakrishnan, A.N., Curry, S.R., Gilligan, P.H., McFarland, L.V., Mellow, M., Zuckerbraun, B.S. (2013) Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. American Journal of Gastroenterology, 108(4): 478-498
Yu, S., Abdelkarim, A., Nawras, A., Hinch, B.T., Mbaso, C., Valavoor, S., Safi, F., Hammersley, J., Tang, J., Assaly, R. (2016) Fecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Difficile Colitis in a Patient With Duchenne Muscular Dystrophy. American Journal of Therapeutics, 23(2): e609-e613